Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells

Journal of Asian Natural Products Research

Volumn 14, Issue 8, 2012, Pages 789-798

  Yuan, Xuan ^a   Zhang, Bo ^b   Chen, Na ^b   Chen, Xiao Yu ^b   Liu, Liang Liang ^b   Zheng, Qiu Sheng ^c   Wang, Zhi Ping ^a  

^a LANZHOU UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

^c YANTAI UNIVERSITY   (China)

Author keywords

apoptosis; HeLa cells; isoliquiritigenin; ROS

Indexed keywords

ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; CATALASE; DICHLOROFLUORESCEIN; FLUORESCENT DYE; ISOLIQUIRITIGENIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SULFORHODAMINE B; TIRON;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYMATIC DEGRADATION; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BUTHIONINE SULFOXIMINE; CELL SURVIVAL; CHALCONES; FREE RADICAL SCAVENGERS; HELA CELLS; HUMANS; MOLECULAR STRUCTURE; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES;

EID: 84865983010     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2012.694873     Document Type: Article

References (25)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun, CA-Cancer J. Clin. 59, 225 (2009).
2. W.L. Hsiao and L. Liu, Planta Med. 76, 1118 (2010).
3. R.S. Kerbel and B.A. Kamen, Nat. Rev. Cancer 4, 423 (2004).
4. M. Tagliaferri, I. Cohen, and D. Tripathy, Semin. Oncol. 28, 121 (2001).
5. K.C. Lai, Y.J. Chiu, Y.J. Tang, K.L. Lin, J.H. Chiang, Y.L. Jiang, H.F. Jen, Y.H. Kuo, S. Agamaya, J.G. Chung, and J.S. Yang, Anticancer Res. 30, 3549 (2010).
6. V.R. Yadav, S. Prasad, B. Sung, and B.B. Aggarwal, Int. Immunopharmacol. 11, 295 (2011).
7. Y.M. Lee, G.S. Jeong, H.D. Lim, R.B. An, Y.C. Kim, and E.C. Kim, Toxicol. In Vitro 4, 776 (2010).
8. Y.L. Hsu, P.L. Kuo, L.C. Chiang, and C.C. Lin, Clin. Exp. Pharmacol. Physiol. 31, 414 (2004).
9. Y.L. Hsu, P.L. Kuo, and C.C. Lin, Life Sci. 77, 279 (2005).
10. J.I. Jung, S.S. Lim, H.J. Choi, H.J. Cho, H.K. Shin, E.J. Kim, W.Y. Chung, K.K. Park, and J.H.Y. Park, J. Nutr. Biochem. 17, 689 (2006).
11. T. Takahashi, M. Baba, H. Nishino, and T. Okuyama, Cancer Lett. 231, 319 (2006).
12. K. Iwashita, M. Kobori, K. Yamaki, and T. Tsushida, Biochemistry 64, 1813 (2000).
13. D.F. Li, Z.H. Wang, H.M. Chen, F. Wei, Q.S. Zheng, J. Shang, and J. Li, Free Radic. Biol. Med. 46, 731 (2009).
14. Y.M. Kim, T.H. Kim, Y.W. Kim, Y.M. Yang, H. Ryu da, S.J. Hwang, J.R. Lee, S.C. Kim, and S.G. Kim, Free Radic. Biol. Med. 49, 1722 (2010).
15. D. Hanahan and R.A. Weinberg, Cell 44, 646 (2011).
16. H.J. Cho, K.E. Baek, S.M. Park, I.K. Kim, I.K. Nam, Y.L. Choi, S.H. Park, M.J. Im, J. Choi, J. Ryu, J.W. Kim, C.W. Lee, S.S. Kang, and J. Yoo, Cancer Lett. 311, 48 (2011).
17. G. Galati, O. Sabzevari, J.X. Wilson, and P.J. O'Brien, Toxicology 177, 91 (2002).
18. O. Sabzevari, G. Galati, M.Y. Moridani, A. Siraki, and P.J. O'Brien, Chem. Biol. Interact. 148, 57 (2004).
19. S. Kanno, E. Matsukawa, A. Miura, A. Shouji, K. Asou, and M. Ishikawa, Biol. Pharm. Bull. 26, 964 (2003).
20. X.H. Yuan, C.L. Lu, N. Yao, L.S. An, B.Q. Yang, C.L. Zhang, and X. Ma, J. Cell. Physiol. 227, 194 (2012).
21. Y.H. Han and W.H. Park, Int. J. Mol. Med. 27, 575 (2011).
22. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd, J. Natl. Cancer Inst. 82, 1107 (1990).
23. T.L. Vanden Hoek, C. Li, Z. Shao, P.T. Schumacker, and L.B. Becker, J. Mol. Cell. Cardiol. 29, 2571 (1997).
24. D. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber, and S.J. Korsmeyer, Nature 348, 334 (1990).
25. J.Y. Cai and D.P. Jones, J. Biol. Chem. 273, 11401 (1998).